New cancer drug ONC-841 enters human testing for advanced tumors
NCT ID NCT06352359
First seen Apr 15, 2026 · Last updated Apr 30, 2026 · Updated 3 times
Summary
This early-stage study tests a new drug called ONC-841 in about 72 people with advanced solid tumors that have spread. The main goals are to check safety, find the best dose, and see if it helps control the cancer. Participants receive the drug through an IV, either alone or with standard treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AdventHealth Medical Group Oncology Research at Celebration
RECRUITINGKissimmee, Florida, 34747, United States
-
Huntsman Cancer Institute, University of Utah
NOT_YET_RECRUITINGSalt Lake City, Utah, 84112, United States
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 770360, United States
-
Norton Cancer Center
RECRUITINGLouisville, Kentucky, 40202, United States
-
Rogel Cancer Center, University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
-
Thomas Jefferson University Hospital
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
-
UF Health Cancer Center, University of Florida
RECRUITINGGainesville, Florida, 32610, United States
-
University of California at Davis Cancer Center
RECRUITINGSacramento, California, 95817, United States
Conditions
Explore the condition pages connected to this study.